The Hematologist

The Hematologist

The Hematologist

167 - A Secondary Consideration: How Real-World Evidence Can Inform Practice in the Management of Patients With Secondary CNS Lymphoma
The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.
167 - A Secondary Consideration: How Real-World Evidence Can Inform Practice in the Management of Patients With Secondary CNS Lymphoma
00:00
00:00
The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

エピソード

167-

A Secondary Consideration: How Real-World Evidence Can Inform Practice in the Management of Patients With Secondary CNS Lymphoma

21 7月 2026
166-

Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

16 6月 2026
165-

Search for the Fountain of Youth: Can Bispecific Antibodies Resurrect Dysfunctional T Cells to Improve Outcomes in Richter Transformation?

08 5月 2026
164-

Not All Clots Are Created Equal: Refining Secondary Prevention of Venous Thromboembolism in Higher-Risk Patients

30 4月 2026
163-

Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia

09 4月 2026